Developer docs
API playgroundTry for free, no card

Search company profiles

SOLVE

Full company profile

uuid0003axo

Namestring
SOLVE
Legal namestring
SOLVE Chemistry
Company typeenum
Private
Founded yearint
2024
Descriptiontext

SOLVE Chemistry is a London-based AI-driven chemistry research and development company spun out of Imperial College London in 2024 as the first joint spin-out from the BASF-Imperial College London partnership that began in 2019. The company combines a proprietary ultra-high-throughput automated laboratory — equipped with online UHPLCs for concentration measurement and capable of collecting chemical reaction data 20 times faster than traditional methods — with interpretive machine learning models to deliver micro-kinetic models and quantitative yield data to pharmaceutical and agrochemical process development teams. Specific deliverables include FAIR (Findable, Accessible, Interoperable, Reusable) datasets, micro-kinetic models produced 50 times faster than standard approaches, and complete response surfaces for solvent optimization delivered in two weeks rather than three months.

The company operates a professional services revenue model with direct enterprise field sales targeting process development teams at major pharmaceutical and agrochemical firms. Named customers include BASF (also strategic partner and initial sponsor), AstraZeneca (N-Acylation kinetics case study), and GSK (pericyclic reaction cascade solvent study using the GSK green score). Pricing is quote-based and not publicly disclosed; engagements span custom experimental campaigns, micro-kinetic modeling, and scale-up prediction. Distribution relies on direct technical consultation, peer-reviewed publications in ACS, RSC, and NeurIPS venues, conference presence, and ecosystem partnerships with reactor and analytics vendors (Ehrfeld Mikrotechnik, Mettler-Toledo, JMP, AiChemy).

SOLVE has raised approximately £4.85 million in equity across a May 2024 pre-seed led by Creator Fund with Chemovator participation and a January 2026 seed round of £4 million led by XTX Ventures with SuperSeed, Creator Fund, and Endgame Capital. The company also participates in a £7 million Innovate UK grant consortium led by Exactmer for bio-based solvents in medicines manufacturing. The team of 15-20 members is led by founders Dr Linden Schrecker (CEO) and Dr Jose Pablo Folch (CSO), with advisors from Imperial College catalysis and chemical engineering faculty and BASF senior principal scientists. Operations are headquartered at Imperial's White City deep tech campus at Scale Space, 58 Wood Lane, London, W12 7RZ.

Short descriptiontext

SOLVE Chemistry is a London-based AI-driven chemistry R&D spinout from Imperial College London that accelerates pharmaceutical and agrochemical process development by combining ultra-high-throughput automated laboratory data collection with proprietary machine learning models.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
chemistry process optimization, high-throughput experimentation, machine learning chemistry, pharmaceutical R&D services, kinetic modeling platform
Industry3 codes
PRIMARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAIALAD
CMC & Pharmaceutical Development (Formulation/Process/Analytical Development)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Research and Development
SECONDARYHLAGAHAA
Small-Molecule API Process Development & Route Scouting
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
NAICS code1 code
  • Scientific Research and Development Services5417
SIC code1 code
  • Laboratory Analytical Instruments3826
Product category
AI-Driven Chemistry R&D
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Chemical Process Development Services
TypeProfessional Services
Description

Provides kinetic insights and quantitative yield data to pharmaceutical and agrochemical companies for accelerating process development of organic synthesis. Revenue derived from service engagements involving experimental data collection, micro-kinetic modeling, and process optimization consulting.

solvechemistry.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

SOLVE Chemistry provides an AI-driven chemistry R&D platform for pharmaceutical and agrochemical companies, combining an ultra-high-throughput automated laboratory with proprietary machine learning models. The platform collects quantitative chemical reaction data 20x faster than traditional methods and delivers kinetic insights, micro-kinetic models, FAIR data outputs, and solvent optimization response surfaces to accelerate process development for organic synthesis.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • Chemical reaction data collected 20 times faster than traditional methods
+6 more records
Product overview1 text field

SOLVE operates across two distinct product lines: SOLVE Px is a pre-trade data and predictive pricing platform for fixed income markets offering AI-powered Confidence Score metrics across corporate and municipal bonds; SOLVE Chemistry is an AI-driven chemistry R&D platform spun out from Imperial College London that provides high-throughput data collection and machine learning for pharmaceutical and agrochemical process development. Both leverage proprietary AI models and automated data collection to deliver faster, more confident decision-making in their respective domains.

Product and service1 record
1AI-Driven Chemistry R&D Platform
CategoryAI-Driven Chemistry R&D
Description

A high-throughput data collection and machine learning platform for pharmaceutical and agrochemical companies that delivers kinetic insights and quantitative yield data in FAIR (Findable, Accessible, Interoperable, Reusable) format. Designed for enterprise process development teams who need to accelerate organic synthesis development, make scale-up decisions with confidence, and explore trade-offs between yield, cost, and sustainability.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-10
Description

Part of UK consortium led by Exactmer that received over £7 million in Innovate UK funding. The consortium includes technology providers, pharmaceutical companies, and research organizations working to industrialize low-greenhouse gas solvents and validate their use in pharmaceutical production.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-09
Description

Parent institution and strategic partner since 2019. SOLVE Chemistry originated from this partnership as their first joint university spin-out. The partnership has supported 35 PhD students and produced numerous patents and new technologies. Imperial's White City deep tech campus hosted the company's initial development after receiving BASF sponsorship.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-09
Description

Major strategic partner and customer. Provided initial sponsorship at Imperial College's White City campus. The partnership began in 2019 and has led to multiple patents and new technologies. BASF continues as a customer and partner in chemical manufacturing innovation including low-greenhouse gas solvent development.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

AI-driven drug discovery company using ML and biophysics for polypharmacology and property prediction. Comparable as an emerging AI-chemistry player, though focused upstream on drug discovery rather than downstream process development.

2AiChemy
TypeDirect peer
Description

Listed as a technology partner on SOLVE's site. AiChemy is an early-stage AI/chemistry company targeting similar process optimization and predictive chemistry use cases for pharma and chemical customers, making it the most directly comparable peer in SOLVE's own ecosystem.

TypeBroad incumbent
Description

Cloud-based R&D platform providing ELN, LIMS, and workflow tools for biotech and pharma R&D. Targets the same enterprise customer personas as SOLVE and competes for process-development software budgets, though Benchling is a horizontal lab informatics layer rather than a chemistry-AI specialist.

TypeBroad incumbent
Description

AI drug discovery and development company operating an end-to-end Pharma.AI platform from target identification to clinical development. Overlaps with SOLVE in AI for chemistry but is much broader in scope and significantly better capitalized.

TypeBroad incumbent
Description

Public computational chemistry platform offering physics-based simulation and ML for drug discovery and materials. Overlaps with SOLVE on ML-driven chemistry insight generation but addresses a much broader discovery-to-process workflow with deeper pharma penetration and substantially more capital.

6CAS (Chemical Abstracts Service)
TypeOthers
Description

Provider of chemistry data, informatics, and predictive tools to R&D organizations. Adjacent rather than directly competitive — CAS supplies data and search infrastructure that complements rather than replaces SOLVE's automated-lab data generation stack.

TypeDirect peer
Description

AI platform for materials and chemical R&D, providing data infrastructure, informatics, and ML models to accelerate formulation and process development. Closely comparable to SOLVE in target market (specialty chemicals, pharma) and value proposition (AI-powered chemistry R&D acceleration), though broader in scope across materials.

TypeBroad incumbent
Description

IBM's AI chemistry platform offering retrosynthesis prediction and reaction outcome modeling. Targets similar pharma and chemistry customers with predictive ML, but is a freely available research tool rather than an integrated automated-lab service, and lacks SOLVE's hardware-based data generation moat.

TypeBroad incumbent
Description

Scientific informatics platform spanning ELN, LIMS, and chemistry data management for pharma R&D. Comparable in serving pharma process-development teams with data and workflow software, though Dotmatics is a much larger established vendor focused on data infrastructure rather than automated experimentation.

TypeBroad incumbent
Description

Large CRO/CDMO offering contract process chemistry and API development services to pharma. Represents the traditional incumbent alternative to SOLVE's automated-lab offering, with deeper existing relationships and global footprint but slower, more manual workflows.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles13 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors7 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

SOLVE

AI-Driven Chemistry R&Dsolvechemistry.com

SOLVE Chemistry is a London-based AI-driven chemistry R&D spinout from Imperial College London that accelerates pharmaceutical and agrochemical process development by combining ultra-high-throughput automated laboratory data collection with proprietary machine learning models.

What SOLVE does

SOLVE Chemistry is a London-based AI-driven chemistry research and development company spun out of Imperial College London in 2024 as the first joint spin-out from the BASF-Imperial College London partnership that began in 2019. The company combines a proprietary ultra-high-throughput automated laboratory — equipped with online UHPLCs for concentration measurement and capable of collecting chemical reaction data 20 times faster than traditional methods — with interpretive machine learning models to deliver micro-kinetic models and quantitative yield data to pharmaceutical and agrochemical process development teams. Specific deliverables include FAIR (Findable, Accessible, Interoperable, Reusable) datasets, micro-kinetic models produced 50 times faster than standard approaches, and complete response surfaces for solvent optimization delivered in two weeks rather than three months.

The company operates a professional services revenue model with direct enterprise field sales targeting process development teams at major pharmaceutical and agrochemical firms. Named customers include BASF (also strategic partner and initial sponsor), AstraZeneca (N-Acylation kinetics case study), and GSK (pericyclic reaction cascade solvent study using the GSK green score). Pricing is quote-based and not publicly disclosed; engagements span custom experimental campaigns, micro-kinetic modeling, and scale-up prediction. Distribution relies on direct technical consultation, peer-reviewed publications in ACS, RSC, and NeurIPS venues, conference presence, and ecosystem partnerships with reactor and analytics vendors (Ehrfeld Mikrotechnik, Mettler-Toledo, JMP, AiChemy).

SOLVE has raised approximately £4.85 million in equity across a May 2024 pre-seed led by Creator Fund with Chemovator participation and a January 2026 seed round of £4 million led by XTX Ventures with SuperSeed, Creator Fund, and Endgame Capital. The company also participates in a £7 million Innovate UK grant consortium led by Exactmer for bio-based solvents in medicines manufacturing. The team of 15-20 members is led by founders Dr Linden Schrecker (CEO) and Dr Jose Pablo Folch (CSO), with advisors from Imperial College catalysis and chemical engineering faculty and BASF senior principal scientists. Operations are headquartered at Imperial's White City deep tech campus at Scale Space, 58 Wood Lane, London, W12 7RZ.

SOLVE firmographics

Firmographics
Name
SOLVE
Legal name
SOLVE Chemistry
Website
https://solvechemistry.com
Company type
Private
Founded year
2024
Operating status
Operating
Headcount range
11–50 employees
Short description
SOLVE Chemistry is a London-based AI-driven chemistry R&D spinout from Imperial College London that accelerates pharmaceutical and agrochemical process development by combining ultra-high-throughput automated laboratory data collection with proprietary machine learning models.
Ownership category
akta.pro rank

SOLVE industry classification

Industry
Product category
AI-Driven Chemistry R&D
NAICS
Scientific Research and Development Services (5417)
SIC
Laboratory Analytical Instruments (3826)
akta.pro industry
PRIMARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAIALAD
CMC & Pharmaceutical Development (Formulation/Process/Analytical Development)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Research and Development
SECONDARYHLAGAHAA
Small-Molecule API Process Development & Route Scouting
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services

Keywords

  • Chemistry process optimization
  • High-throughput experimentation
  • Machine learning chemistry
  • Pharmaceutical R&D services
  • Kinetic modeling platform

Where SOLVE is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Offices2 records

Markets served

SOLVE business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

  1. Chemical Process Development Services: Provides kinetic insights and quantitative yield data to pharmaceutical and agrochemical companies for accelerating process development of organic synthesis. Revenue derived from service engagements involving experimental data collection, micro-kinetic modeling, and process optimization consulting.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

SOLVE product offering

Product offering

Core offering

SOLVE Chemistry provides an AI-driven chemistry R&D platform for pharmaceutical and agrochemical companies, combining an ultra-high-throughput automated laboratory with proprietary machine learning models. The platform collects quantitative chemical reaction data 20x faster than traditional methods and delivers kinetic insights, micro-kinetic models, FAIR data outputs, and solvent optimization response surfaces to accelerate process development for organic synthesis.

Product overview

SOLVE operates across two distinct product lines: SOLVE Px is a pre-trade data and predictive pricing platform for fixed income markets offering AI-powered Confidence Score metrics across corporate and municipal bonds; SOLVE Chemistry is an AI-driven chemistry R&D platform spun out from Imperial College London that provides high-throughput data collection and machine learning for pharmaceutical and agrochemical process development. Both leverage proprietary AI models and automated data collection to deliver faster, more confident decision-making in their respective domains.

Differentiator

Problem solved

Functional benefit

Products and services

  • AI-Driven Chemistry R&D Platform A high-throughput data collection and machine learning platform for pharmaceutical and agrochemical companies that delivers kinetic insights and quantitative yield data in FAIR (Findable, Accessible, Interoperable, Reusable) format. Designed for enterprise process development teams who need to accelerate organic synthesis development, make scale-up decisions with confidence, and explore trade-offs between yield, cost, and sustainability.

Quantifiable outcome

  • Chemical reaction data collected 20 times faster than traditional methods
  • +6 more outcomes

Companies that use SOLVE

Customer profile

Named customers3 records

Segments2 records

Ideal customer profiles2 records

SOLVE technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability5 records

Feature5 records

SOLVE partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • Exactmer (UK Consortium Lead)coreStrategic or Co-development Partner · 10 March 2026Part of UK consortium led by Exactmer that received over £7 million in Innovate UK funding. The consortium includes technology providers, pharmaceutical companies, and research organizations working to industrialize low-greenhouse gas solvents and validate their use in pharmaceutical production.
  • Imperial College LondoncoreStrategic or Co-development Partner · 9 February 2026Parent institution and strategic partner since 2019. SOLVE Chemistry originated from this partnership as their first joint university spin-out. The partnership has supported 35 PhD students and produced numerous patents and new technologies. Imperial's White City deep tech campus hosted the company's initial development after receiving BASF sponsorship.
  • BASFcoreStrategic or Co-development Partner · 9 February 2026Major strategic partner and customer. Provided initial sponsorship at Imperial College's White City campus. The partnership began in 2019 and has led to multiple patents and new technologies. BASF continues as a customer and partner in chemical manufacturing innovation including low-greenhouse gas solvent development.

Scale indicators8 records

Recent moves7 records

Expansion highlights6 records

SOLVE competitors and assessment

Company assessment

Emerging players

  • Cyclica: AI-driven drug discovery company using ML and biophysics for polypharmacology and property prediction. Comparable as an emerging AI-chemistry player, though focused upstream on drug discovery rather than downstream process development.

Direct peers

  • AiChemy: Listed as a technology partner on SOLVE's site. AiChemy is an early-stage AI/chemistry company targeting similar process optimization and predictive chemistry use cases for pharma and chemical customers, making it the most directly comparable peer in SOLVE's own ecosystem.
  • Citrine Informatics: AI platform for materials and chemical R&D, providing data infrastructure, informatics, and ML models to accelerate formulation and process development. Closely comparable to SOLVE in target market (specialty chemicals, pharma) and value proposition (AI-powered chemistry R&D acceleration), though broader in scope across materials.

Broad incumbents

  • Benchling: Cloud-based R&D platform providing ELN, LIMS, and workflow tools for biotech and pharma R&D. Targets the same enterprise customer personas as SOLVE and competes for process-development software budgets, though Benchling is a horizontal lab informatics layer rather than a chemistry-AI specialist.
  • Insilico Medicine: AI drug discovery and development company operating an end-to-end Pharma.AI platform from target identification to clinical development. Overlaps with SOLVE in AI for chemistry but is much broader in scope and significantly better capitalized.
  • Schrödinger: Public computational chemistry platform offering physics-based simulation and ML for drug discovery and materials. Overlaps with SOLVE on ML-driven chemistry insight generation but addresses a much broader discovery-to-process workflow with deeper pharma penetration and substantially more capital.
  • IBM RXN: IBM's AI chemistry platform offering retrosynthesis prediction and reaction outcome modeling. Targets similar pharma and chemistry customers with predictive ML, but is a freely available research tool rather than an integrated automated-lab service, and lacks SOLVE's hardware-based data generation moat.
  • Dotmatics: Scientific informatics platform spanning ELN, LIMS, and chemistry data management for pharma R&D. Comparable in serving pharma process-development teams with data and workflow software, though Dotmatics is a much larger established vendor focused on data infrastructure rather than automated experimentation.
  • AMRI (Eurofins Discovery): Large CRO/CDMO offering contract process chemistry and API development services to pharma. Represents the traditional incumbent alternative to SOLVE's automated-lab offering, with deeper existing relationships and global footprint but slower, more manual workflows.

Others

  • CAS (Chemical Abstracts Service): Provider of chemistry data, informatics, and predictive tools to R&D organizations. Adjacent rather than directly competitive — CAS supplies data and search infrastructure that complements rather than replaces SOLVE's automated-lab data generation stack.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

SOLVE social profiles

Digital presence

SOLVE compliance and trust

Trust signal

Compliance2 records

SOLVE financial estimates

Financial estimate

Revenue estimate

Valuation estimate

SOLVE leadership team

Management profile

Number of profiles

Profiles13 records

SOLVE funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

SOLVE M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SOLVE

What does SOLVE do?

SOLVE Chemistry provides an AI-driven chemistry R&D platform for pharmaceutical and agrochemical companies, combining an ultra-high-throughput automated laboratory with proprietary machine learning models. The platform collects quantitative chemical reaction data 20x faster than traditional methods and delivers kinetic insights, micro-kinetic models, FAIR data outputs, and solvent optimization response surfaces to accelerate process development for organic synthesis.

Is SOLVE a public or private company?

SOLVE is a private company. It is classified as venture growth investor backed and is currently operating.

When was SOLVE founded?

SOLVE was founded in 2024. It employs 11 to 50 people.

Where is SOLVE based?

SOLVE is headquartered in London, United Kingdom, in the Europe region.

How does SOLVE make money?

One revenue line is on record: chemical Process Development Services.

Who are SOLVE's main competitors?

Cyclica is listed as an emerging player. Direct peers are AiChemy and Citrine Informatics. Broad incumbents are Benchling, Insilico Medicine, Schrödinger, IBM RXN, Dotmatics and AMRI (Eurofins Discovery). CAS (Chemical Abstracts Service) is listed as an others.

Does SOLVE have an API?

Yes. SOLVE Px API provides AI-powered predictive pricing for corporate bonds with Confidence Score, available through API, Excel Add-In, and Feeds. The Confidence Score quantifies pricing uncertainty on a standardized 1-10 scale across more than 250,000 investment-grade and high-yield corporate bonds, categorizing confidence as Low (1-2), Medium (3-6), or High (7-10).

What industry is SOLVE in?

SOLVE's product category is AI-Driven Chemistry R&D. Its primary akta.pro industry code is HLAGAJAO, AI/ML Platforms for Drug Discovery & Experiment Optimization, with a secondary code of HLAIALAD, CMC & Pharmaceutical Development (Formulation/Process/Analytical Development). Its NAICS code is 5417 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
AtalayarIndra Group forges new partnerships in Catalonia to modernise defenceIndra Group formalised 19 strategic agreements with Catalan companies, SMEs, start-ups, and research centres at the 4th National Defence Industry Ecosystem Meeting in Barcelona. The partnerships aim to integrate high-value technologies, reduce development times, and accelerate operational implementation in defence, security, space, and mobility sectors.SalesTech StarSOLVE Expands Corporate Bond Predictive Pricing with Launch of Confidence Score for SOLVE Px™SOLVE, a provider of pre-trade data and predictive pricing for fixed income markets, announced the launch of Confidence Score for Corporate Bonds, an AI-powered metric that quantifies pricing uncertainty on a standardized 1-10 scale across more than 250,000 investment-grade and high-yield corporate bonds. The feature, available through SOLVE Px API, Excel Add-In, and Feeds, is designed to help fixed income professionals assess price reliability by categorizing confidence as Low (1-2), Medium (3-6), or High (7-10). This launch expands on SOLVE's previous rollout of Confidence Score for municipal bonds and represents part of the company's broader effort to enhance transparency in AI-driven fixed income pricing.PoliticshomeA unique industrial chemical partnership is addressing real-world challengesBASF and Imperial College London have been partnered since 2019 to develop innovative chemical manufacturing solutions, including sustainable production technologies, AI-optimized processes, and pandemic pharmaceutical readiness. The partnership has supported 35 PhD students, produced numerous patents and new technologies, and recently launched SOLVE Chemistry as their first joint university spin-out to commercialize AI-based chemical manufacturing solutions. The partners aim to accelerate technology translation from lab-scale to commercial production, with potential to create new economic opportunities and high-skilled employment in the UK.UktechnewsSOLVE Chemistry secures £4 million Seed Investment led by XTX VenturesLondon-based SOLVE Chemistry has raised £4 million in seed funding to expand its AI-driven chemistry R&D platform that helps pharmaceutical and agrochemical manufacturers accelerate product development. The investment round was led by XTX Ventures with participation from SuperSeed, Creator Fund, and climate fund Endgame Capital, and will enable the company to quadruple production capacity and expand its team. SOLVE Chemistry, a spinout from Imperial College London, uses novel ultra-high-throughput data collection hardware to obtain chemical reaction data 20 times faster than traditional methods and is already working with clients including German chemical giant BASF.LinkedInWe’re thrilled to announce SOLVE Chemistry's £4mn seed round fuelling the growth of our capacity and capabilities to provide real scalable value to our customers. As highlighted today on Sky News…SOLVE Chemistry, a London-based spin-out from Imperial College London, has secured £4 million in seed funding from top-tier investors to expand its capacity and capabilities in providing faster, safer, and more cost-effective solutions for agrichemical and pharma companies bringing products to market. The company, which originated at Imperial's White City deep tech campus after receiving initial sponsorship from BASF, has grown into larger laboratory facilities in just over 18 months. The funding is aimed at enabling the company to deliver scalable value to customers in the agrichemical and pharmaceutical sectors.Imperial College LondonImperial and SOLVE Chemistry bring chemical reaction data to machine learningResearchers from Imperial and its spinout company SOLVE Chemistry presented a new chemical dataset at the NeurIPS conference aimed at enhancing the use of machine learning in predicting solvent performance for industrial chemistry. The dataset focuses on catechol rearrangement, offering substantial data points to improve prediction models for solvents and temperatures. This initiative could lead to more sustainable solvent usage and improved yields in chemical reactions.